Steven P. Weitzman, M.D., F.A.C.E.
Department of Endocrine Neoplasia and Hormonal Disorders, Division of Internal Medicine
About Dr. Steven P. Weitzman
Dr. Weitzman earned his medical degree from the University at Buffalo School of Medicine, graduating with honors. He completed his residency in Internal Medicine at Albert Einstein College of Medicine/Long Island Jewish Medical Center, where he also served as Chief Resident. He then pursued fellowship training in Endocrinology, Diabetes, and Metabolism at Stony Brook University School of Medicine and subsequently joined the faculty there as Assistant Professor.
In 2014, Dr. Weitzman became the inaugural fellow in Oncologic Endocrinology at The University of Texas MD Anderson Cancer Center, receiving comprehensive training in endocrine neoplasia. After completing this fellowship, he joined the MD Anderson faculty, where he is now a Clinical Associate Professor in the Department of Endocrine Neoplasia and Hormonal Disorders.
Board certified in Endocrinology, Diabetes, and Metabolism, Dr. Weitzman is a Fellow of the American Association of Clinical Endocrinology and an active member of the American Thyroid Association and The Endocrine Society. His clinical and research interests include thyroid cancer, endocrine complications of cancer therapy, and quality improvement in endocrine care.
Education & Training
Postgraduate Training
| 2019-2020 | LEADing Others: Accelerate Program, Leadership Development, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2014-2015 | Oncologic Endocrinology Fellowship, Endocrine Neoplasia, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2014-2014 | Fundamentals of Quality Improvement Certificate, Quality Education, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2012-2013 | Medical Education Research Certificate (MERC) Program, Educational Research, The Association of American Medical Colleges, Washington, DC |
| 2012-2013 | Endocrine Certification in Neck Ultrasound (ECNU) Program, Neck Ultrasonography, The American College of Endocrinology, Jacksonville, Florida |
| 2006-2008 | Clinical Fellowship, Endocrinology, Diabetes and Metabolism, Stony Brook University School of Medicine, Stony Brook, New York |
| 2005-2006 | Clinical Residency, Chief Resident in Internal Medicine, Long Island Jewish Medical Center, New Hyde Park, New York |
| 2002-2005 | Clinical Residency, Internal Medicine, Long Island Jewish Medical Center, New Hyde Park, New York |
Licenses & Certifications
| 2024 | Alabama License |
| 2023 | Georgia License |
| 2023 | Oklahoma License |
| 2023 | Tennessee License |
| 2023 | Washington License |
| 2023 | Louisiana License |
| 2023 | Arizona License |
| 2021 | Florida Telehealth License |
| 2014 | Texas License |
| 2013 | ECNU (Endocrine Certification in Neck Ultrasound), American College of Endocrinology |
| 2008 | Endocrinology, Diabetes, and Metabolism, American Board of Internal Medicine |
Experience & Service
Faculty Academic Appointments
Associate Professor, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2018 - 2021
Assistant Professor, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2015 - 2018
Administrative Appointments/Responsibilities
Faculty EHR Officer, Endocrine Neoplasia & Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX, 2018 - 2020
Endocrine Rotation Site Director, Internal Medicine Residency Program, Endocrine Neoplasia & Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2016 - 2020
Other Professional Positions
Consultant, MD Anderson Cancer Network, Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2026 - Present
Abstract Submission Reviewer, The Endocrine Society, Washington, D.C, District of Columbia, 2025
Subject Matter Expert for Test Bank Question Revision, Endocrine Certification in Neck Ultrasound (ECNU) Program Committee, The American Association of Clinical Endocrinologists (AACE), Jacksonville, FL, 2018 - 2019
Judge, Trainee Poster Contest, 87th Annual Meeting of the American Thyroid Association (ATA), Victoria, 2017
Judge, Trainee Poster Contest, 86th Annual Meeting of the American Thyroid Association (ATA), Denver, CO, 2016
Applicant Interviewer, Internal Medicine Residency Program, The University of Texas MD Anderson Cancer Center and Baylor College of Medicine, Houston, TX, 2016 - 2020
Core Faculty, Oncologic Endocrinology Fellowship Program, The University of Texas MD Anderson Cancer Center, Houston, TX, 2015 - 2022
OneConnect Super User, The University of Texas MD Anderson Cancer Center, Houston, TX, 2015 - 2020
Applicant Interviewer, Endocrinology, Diabetes & Metabolism Fellowship, Baylor College of Medicine, Houston, TX, 2015 - 2019
Applicant Interviewer, Endocrinology, Diabetes & Metabolism Fellowship, Renaissance School of Medicine at Stony Brook University, Stony Brook, NY, 2009 - 2014
Intramural Institutional Committee Activities
Member, Insulin Pump Project, The University of Texas MD Anderson Cancer Center, 2018 - 2020
Member, Oncologic Endocrinology Fellow Selection Committee, The University of Texas MD Anderson Cancer Center, 2016 - 2021
Member, Pharmacy and Therapeutics Committee, The University of Texas MD Anderson Cancer Center, 2016 - 2021
Member, Multidisciplinary Thyroid PRO (Patient Reported Outcomes) Pilot Team, The University of Texas MD Anderson Cancer Center, 2016 - 2020
Member, Endocrine's Clinical Operations Committee, The University of Texas MD Anderson Cancer Center, 2016 - 2019
Member, House Staff Senate, The University of Texas MD Anderson Cancer Center, 2015
Member, Anaplastic Thyroid Cancer and Differentiated Thyroid Cancer Translational Research Working Group, The University of Texas MD Anderson Cancer Center, 2014 - 2020
Member, Medullary Thyroid Cancer Translational Research Working Group, The University of Texas MD Anderson Cancer Center, 2014 - 2020
Member, Pharmacy and Therapeutics Committee, Northport Veterans Administration Medical Center, 2011 - 2014
Extramural Institutional Committee Activities
Panel Member,, Internal Accreditation Council for Graduate Medical Education (ACGME) Fellowship Program Review Panel, Renaissance School of Medicine at Stony Brook University, 2007 - 2008
Honors & Awards
| 2024 | Division of Internal Medicine Research Retreat Quality Improvement Poster Session 1st Place, The University of Texas MD Anderson Cancer Center |
| 2024 | Division of Internal Medicine Research Retreat Quality Improvement Poster Session 3rd Place, The University of Texas MD Anderson Cancer Center |
| 2022 | Fellow of Endocrine Alliance Academy (FEAA), Endocrine Alliance |
| 2020 | Top 1% Provider in Patient Experience, Press Ganey |
| 2018 - 2019 | Top 10 percentile nationally in patient care experience, U.S. Department of Health & Human Services Agency for Healthcare Research and Quality |
| 2017 | Top 1 percentile nationally in patient care experience, U.S. Department of Health & Human Services Agency for Healthcare Research and Quality |
| 2013 - 2014 | Newsday: Top Doctors on Long Island, Castle Connolly |
| 2013 - 2014 | Top Doctors: New York Metro Area, Castle Connolly |
| 2012 | Fellow of the American Association of Clinical Endocrinology (FACE), American College of Endocrinology |
| 1999 - 2000 | Dean’s Letter of Commendation, University at Buffalo School of Medicine and Biomedical Sciences |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2024. Improving Access and Quality Care for Immune Checkpoint Inhibitor Related Thyroid Dysfunction. Poster. IOTOX Symposium. Houston, Texas, US.
- 2023. Safety Monitoring for Patients With Thyroid Cancer on Targeted Therapy Outside of a Clinical Trial. Invited. Division of Internal Medicine and Cancer Survivorship Grand Rounds. Houston, TX, US.
- 2023. Enhancing Toxicity Monitoring for Patients with Advanced Thyroid Cancer on Targeted Therapy. Poster. IOTOX Symposium. Houston, Texas, US.
- 2018. The Evaluation of Thyroid Nodules. Invited. MD Anderson Thyroid Carcinoma Educational Program. Houston, TX, US.
- 2018. Clinical Significance of a Rare BRAF Mutation in Thyroid Cancer. Invited. Internal Medicine Grand Rounds. Houston, TX, US.
- 2018. Making the Diagnosis: Evaluation of Thyroid Nodules. Invited. MD Anderson Thyroid Carcinoma Educational Program. Houston, TX, US.
- 2016. Medullary Thyroid Carcinoma Tumor Board - Clinical Case Discussion. Invited. MD Anderson Medullary Thyroid Carcinoma Academic and Clinical Learning Summit. Houston, TX, US.
Regional Presentations
- 2023. Setting up a Remote CGMS Clinic. Invited. Texas Endocrinology Association / Texas Endocrine Surgeon Society 2023 Annual Meeting. Houston, TX, US.
- 2019. The Use of Molecular Testing by Endocrinologists. Invited. Houston Society of Clinical Pathologist 60th Annual Spring Symposium. Houston, TX, US.
- 2017. Not Your Usual Thyroid Cancer: a Case Based Discussion of the Management of Complex Thyroid Cancer. Invited. Endocrine Grand Rounds. Stony Brook, NY, US.
- 2017. Locally Advanced and/or Metastatic Thyroid Cancer: What New Options Are on the Horizon?. Invited. An Interdisciplinary Thyroid Cancer Symposium. Tempe, AZ, US.
- 2017. Case Presentations. Invited. An Interdisciplinary Thyroid Cancer Symposium. Tempe, AZ, US.
- 2017. Systemic Therapy for Thyroid Cancer: Who, When and Why?. Invited. An Interdisciplinary Thyroid Cancer Symposium. Tempe, AZ, US.
- 2017. Management of Radioiodine Refractory Differentiated Thyroid Cancer: What’s Next When the Magic Bullet Isn't Effective?. Invited. Management of Radioiodine Refractory Differentiated Thyroid Cancer: What’s Next When the Magic Bullet Isn't Effective?. Stony Brook, NY, US.
- 2009. Defeating Diabetes. Invited. The National Kidney Foundation Annual Spring Conference. Plainview, NY, US.
National Presentations
- 2020. Thyroid Ultrasound Hands-On Practicum. Invited. Endocrine University. Houston, TX, US.
- 2019. E. Chester Ridgway Trainee Day Combined Clinical and Basic Morning Symposium. Invited. 89th Annual Meeting of the American Thyroid Association. Chicago, IL, US.
- 2019. E. Chester Ridgway Trainee Day Clinical Afternoon Breakout Symposium. Invited. 89th Annual Meeting of the American Thyroid Association. Chicago, IL, US.
- 2017. Thyroid Neoplasia and Differentiated Thyroid Cancer. Invited. 7th Current Concepts in the Management of Thyroid and Parathyroid Neoplasms. Houston, TX, US.
- 2017. Hands-On Ultrasound Practicum. Invited. 7th Current Concepts in the Management of Thyroid and Parathyroid Neoplasms. Houston, TX, US.
- 2016. Medullary Thyroid Cancer with Bone Metastases and the Effect of Antiresorptive Agents on Skeletal Related Events: Experience at MD Anderson Cancer Center. Invited. The Endocrine Society's 98th Annual Meeting and Expo. Boston, MA, US.
- 2015. Salvage Therapy: When a Tyrosine Kinase Inhibitor Fails in Advanced Medullary Thyroid Cancer. Invited. Endocrine Society's 97th Annual Meeting and Expo. San Diego, CA, US.
- 1995. Grieving the Loss of Romantic Love Relationships in Young Adulthood. Invited. 72nd Annual Meeting of the American Orthopsychiatric Association. Chicago, IL, US.
International Presentations
- 2025. Glycemia Risk Index (GRI) in Patients withCancer and Diabetes Using CGM. Invited. 25th Annual Diabetes Technology Meeting (DTM). Burlingame, US.
- 2019. Thyroid Function: Case Discussions. Invited. 89th Annual Meeting of the American Thyroid Association. Chicago, US.
- 2019. Surveillance in Differentiated Thyroid Cancer: A Status Update. Invited. 22nd International Thyroid Cancer Survivors’ Conference. Denver, US.
- 2019. Thyroid Ultrasound Practicum. Invited. 89th Annual Meeting of the American Thyroid Association. Chicago, US.
- 2018. Thyroid Function: Case Discussions. Invited. 88th Annual Meeting of the American Thyroid Association. Washington, US.
- 2018. Thyroid Ultrasound Practicum. Invited. 88th Annual Meeting of the American Thyroid Association. Washington, US.
- 2018. Surgical Symposium: Multidisciplinary Management of Graves’ Disease 2018. Invited. 88th Annual Meeting of the American Thyroid Association. Washington, US.
- 2017. Thyroid Nodules: Case Discussions. Invited. 87th Annual Meeting of the American Thyroid Association. Victoria, CA.
- 2017. Career Tracks. Invited. 87th Annual Meeting of the American Thyroid Association. Victoria, CA.
- 2017. Sonographic Assessment of Thyroid Nodules. Invited. 87th Annual Meeting of the American Thyroid Association. Victoria, CA.
- 2016. Thyroid Nodules: Case Discussions. Invited. 86th Annual Meeting of the American Thyroid Association. Denver, US.
- 2016. Comprehensive Neck Ultrasound. Invited. 86th Annual Meeting of the American Thyroid Association. Denver, US.
- 2015. Facilitating Anaplastic Thyroid Cancer Specialized Treatment (FAST): a Model for Increasing Enrollment to Anaplastic Thyroid Cancer (ATC) Clinical Trials. Invited. 15th International Thyroid Congress. Orlando, US.
Selected Publications
Peer-Reviewed Articles
- Williams JK, Brinkman AK, Salami-Henry AY, Kikani NJ, Weitzman SP. Treatment-Refractory Hypothyroidism Due to Proteinuria During Combined Immune Checkpoint and Tyrosine Kinase Inhibitor Therapy – A Case Report. Clin Med Insights Endocrinol Diabetes 19, 2026. e-Pub 2026. PMID: 42473548.
- Liu JB, Szabo Yamashita T, Rollins JL, Lee-Kim S-H, Avula KC, Chacko R, Williams LA, Zafereo ME, Maniakas A, Wang JR, Busaidy NL, Cabanillas ME, Castellanos LC, Chaudhri A, Dadu R, Hu MI, Jimenez C, Ying AK, Sherman SI, Waguespack SG, Weitzman SP, Graham PH, Perrier ND, Shinn EH, Roth ME, Habra MA, Grubbs EG, Fisher SB. Patient-Reported Symptom Burden Among Thyroid Cancer Survivors: Retrospective Cohort Study. JCO Clin Cancer Inform 10(3), 2026. e-Pub 2026. PMID: 42391597.
- Osafehinti DA, Thosani S, Weitzman SP. Trends in Glycemic Risk Index Over Time in Patients with Diabetes and Cancer Undergoing Remote Continuous Glucose Monitoring. J Diabetes Sci Technol, 2026. e-Pub 2026. PMID: 42490146.
- Umpierrez GE, Shah VN, Brady V, Clements MA, Espinoza J, Healey E, Kohn MA, Maahs DM, Oiknine R, Seley JJ, Weitzman SP, Kerr D, Akturk HK, Aleppo G, Al-Sofiani ME, Cengiz E, Doyle FJ 3rd, Ebekozien O, Edelman SV, Ekhlaspour L, Freckmann G, Heinemann L, Hirsch IB, Hsiao VC, Kim SH, Kovatchev B, Lal RA, Lind M, Mader JK, Mathioudakis N, McLaughlin T, Meo SA, Osafehinti DA, Phillip M, Prahalad P, Scheinker D, Snyder MP, Wang J, Wong JC, Wright EE, Shao MM, Scheideman AF, DuNova AY, Klonoff DC. Integrating the Glycemia Risk Index Into Clinical Practice and Research: A Consensus Report. J Diabetes Sci Technol 20(3):695-707, 2026. e-Pub 2026. PMID: 41793701.
- Crowder VM, Williams JK, Weitzman SP. Granulomatous Hypophysitis Masquerading as a Pituitary Macroadenoma: A Diagnostic Challenge. AACE Endocrinol Diabetes 13(3):488-489, 2026. e-Pub 2026. PMID: 42221391.
- Brinkman AK, Salami-Henry AY, Aaron-Brija LA, Hannah FM, Hu MI, Hwang L-L, Patel RP, Rollins JL, Sherman SI, Williams JK, Kikani NJ, Weitzman SP. Increasing Access and Quality Care for Immune Checkpoint Inhibitor-Related Thyroid Dysfunction. JCO Oncol Pract 19, 2025. e-Pub 2025. PMID: 41418091.
- Hu MI, Waguespack SG, Dosiou C, Ladenson PW, Livhits MJ, Wirth LJ, Sadow PM, Krane JF, Stack BC, Zafereo ME, Ali SZ, Weitzman SP, Hao Y, Babiarz JE, Kennedy GC, Kloos RT. Afirma Genomic Sequencing Classifier and Xpression Atlas Molecular Findings in Consecutive Bethesda III-VI Thyroid Nodules. J Clin Endocrinol Metab 106(8):2198 - 2207, 2021. e-Pub 2021. PMID: 34009369.
- Qiu L, Weitzman SP, Nastoupil LJ, Williams MD, Medeiros LJ, Vega F. Disseminated ALK-positive Histiocytosis with KIF5B-ALK Fusion in an Adult. Leukemia & Lymphoma 62(5):1234-1238, 2021. e-Pub 2021. PMID: 33353436.
- Jozaghi Y, Zafereo ME, Perrier ND, Wang JR, Grubbs E, Gross ND, Fisher S, Sturgis EM, Goepfert RP, Lai SY, Best C, Busaidy NL, Cabanillas ME, Dadu R, Gagel RF, Habra MA, Hu MI, Jimenez C, Sherman SI, Thosani S, Varghese J, Waguespack SG, Weitzman S, Ying AK, Graham PH. Endocrine Surgery in the Coronavirus Disease 2019 Pandemic: Surgical Triage Guidelines. Head Neck 42(6):1325-1328, 2020. e-Pub 2020. PMID: 32437031.
- Debnam JM, Vu T, Sun J, Wei W, Krishnamurthy S, Zafereo ME, Weitzman SP, Garg N, Ahmed S. Vascular Flow on Doppler Sonography May Not Be a Valid Characteristic to Distinguish Colloid Nodules from Papillary Thyroid Carcinoma. Gland Surg 8(5):461-468, 2019. e-Pub 2019. PMID: 31741876.
- Cabanillas ME, Williams MD, Gunn GB, Weitzman SP, Burke L, Busaidy NL, Ying AK, Yiin YH, William WN, Lu C, Lai SY. Facilitating Anaplastic Thyroid Cancer Specialized Treatment: a Model for Improving Access to Multidisciplinary Care for Patients with Anaplastic Thyroid Cancer. Head Neck 39(7):1291-1295, 2017. e-Pub 2017. PMID: 28452157.
- Xu JY, Murphy WA, Milton DR, Jimenez C, Rao SN, Habra MA, Waguespack SG, Dadu R, Gagel RF, Ying AK, Cabanillas ME, Weitzman SP, Busaidy NL, Sellin RV, Grubbs E, Sherman SI, Hu MI. Bone Metastases and Skeletal-Related Events in Medullary Thyroid Carcinoma. J Clin Endocrinol Metab 101(12):4871-4877, 2016. e-Pub 2016. PMID: 27662441.
- Weitzman SP, Ginsburg KC, Carlson HE. Colesevelam Hydrochloride and Lanthanum Carbonate Interfere with the Absorption of Levothyroxine. Thyroid 19(1):77-9, 2009. e-Pub 2009. PMID: 19119983.
Invited Articles
- Cubb TD, Weitzman SP. Re–Do Surgery Is Not Always Necessary: Active Surveillance of Cervical Lymph Node Metastases in Patients with Differentiated Thyroid Cancer. Clinical Thyroidology 35(3):105-109, 2023. e-Pub 2023. PMID: 36680747.
- Weitzman SP, Sherman SI. Novel Drug Treatments of Progressive Radioiodine-Refractory Differentiated Thyroid Cancer. Endocrinol Metab Clin North Am 48(1):253-268, 2019. e-Pub 2019. PMID: 30717907.
- Weitzman SP. The Use of Vaginal Estrogen in Women With a History of Estrogen-Dependent Breast Cancer: American College of Obstetricians and Gynecologists’ Committee on Gynecologic Practice. Breast Diseases: A Year Book Quarterly 27(3):228-229, 2016. e-Pub 2016.
- Weitzman SP, Cabanillas ME. The Treatment Landscape in Thyroid Cancer: A Focus on Cabozantinib. Cancer Manag Res 2015(7):265-78, 2015. e-Pub 2015. PMID: 26316818.
Review Articles
- Iyer PC, Kikani N, Khan S, Chaudhary A, Pagnotti G, Best C, Weitzman S, Mehta P, Lavis V, Thosani S, Gandhi A, Schneider Aguirre R, Varghese J, Guise T, Dadu R. The Evolving Management of Endocrine Disorders Induced by Checkpoint Inhibitors: Insights From the CIITED Group. Expert Rev Endocrinol Metab 21(1):29-41, 2026. e-Pub 2026. PMID: 41307239.
Abstracts
- Osafehinti DA, Thosani S, Weitzman SP. Investigating Glycemic Risk Index Trends for Patients with Comorbid Cancer and Diabetes Evaluated in Remote Monitoring Clinic. J Diabetes Sci Technol 20(2):465-586, 2026. e-Pub 2026.
- Hamidi S, Waguespack SG, Wang JR, Weitzman SP, Zafereo ME, Busaidy NL, Dosiou C, Vodopivec Kuri D, Chen Y, Hao Y, Alshalalfa M, Klopper JP, Hu MI. The Genomic Landscape of 250,000+ Thyroid Nodules Undergoing Exome-enriched RNA Sequencing. 2025 American Thyroid Association Annual Meeting, 2025. e-Pub 2025.
- Patel R, Cubb TD, Weitzman SP. Thyroid Nodule Evaluation Challenges: A Case Report of Secondary Thyroid Malignancy. 2025 American Thyroid Association Annual Meeting, 2025. e-Pub 2025.
- Hamidi S, Waguespack SG, Wang JR, Weitzman SP, Zafereo ME, Busaidy NL, Dosiou C, Vodopivec Kuri D, Chen Y, Hao Y, Alshalalfa M, Klopper JP, Hu MI. The Genomic Landscape of 250,000+ Thyroid Nodules Undergoing Exome-enriched RNA Sequencing. 17th International Thyroid Congress (ITC) 69(S3):67, 2025. e-Pub 2025.
- Brinkman AK, Salami-Henry A, Aaron-Brija L, Hannah F, Hu MI, Hwang L-L, Kikani NJ, Patel RP, Rollins JL, Williams JK, Weitzman SP. Immune Checkpoint Inhibitor Related Thyroid Dysfunction: A Quality Improvement Project to Improve Access to Endocrine Care and Expedite Normalization of Thyroid Hormone Levels. 2024 American Thyroid Association Annual Meeting 34(S1), 2024. e-Pub 2024.
- Williams JK, Brinkman AK, Salami-Henry A, Kikani NJ, Weitzman SP. A Unique Patient With Immune Checkpoint Inhibitor-Induced Thyroiditis: What’s the Kidney Have to Do With It?. 2024 American Thyroid Association Annual Meeting 34(S1), 2024. e-Pub 2024.
- Ramos H, Hamidi S, Faria S, Dadu R, Hu MI, Busaidy N, Waguespack S, Weitzman SP, Sherman SI, Cabanillas M. Redifferentiation therapy (RDT) in differentiated thyroid carcinomas (DTC): Real-World data of a large cohort of patients. 2024 American Thyroid Association Annual Meeting 34(S1), 2024. e-Pub 2024.
- Hamidi S, Castellanos LE, Thosani S, Best CJ, Sherman SI, Dadu R, Brinkman AK, Khoja M, Hu MI, Waguespack SG, Weitzman SP. Real-Life Safety Monitoring for Patients with Advanced Thyroid Cancer on Targeted Therapy: A Quality Improvement Project. The Endocrine Society 106th Annual Meeting 8(Supplement 1), 2024. e-Pub 2024.
- Brinkman AK, Salami-Henry A, Aaron-Brija L, Hannah F, L-L H, Kikani N, Patel RP, Williams JK, Weitzman SP. Improving Access and Quality Care for Immune Checkpoint Inhibitor Related Thyroid Dysfunction. 2024 Division of Internal Medicine Research Retreat, 2024.
- Hamidi S, Castellanos LE, Thosani S, Best CJ, Sherman SI, Dadu R, Brinkman AK, Sadruddin MK, Hu MI, Waguespack SG, Weitzman SP. Enhancing Toxicity Monitoring for Patients with Advanced Thyroid Cancer on Targeted Therapy. 2024 Division of Internal Medicine Research Retreat, 2024.
- Wirth LJ, Grubbs EG, Livhits MJ, Sherman SI, Weitzman SP, Dosiou C, Ladenson PW, Hao Y, Babiarz JE, Kennedy GC, Kloos RT. Identification of Novel and Rare Receptor Tyrosine Kinase Fusions in Thyroid Fine Needle Aspirates. The Endocrine Society 102nd Annual Meeting 4(Supplement 1), 2020. e-Pub 2020.
- Serrano IA, Ahmad S, Dadu R, Graham P, Weitzman SP. Ectopic ACTH Syndrome: An Aggressive Presentation Due to Metastatic Liver Cancer of Unknown Primary. The Endocrine Society 102nd Annual Meeting 4(Supplement 1), 2020. e-Pub 2020.
- Falcone R, Waguespack S, Dadu R, Sherman SI, Busaidy NL, Hu MI, Jimenez C, Weitzman SP, Cabanillas ME. Redifferentiation Radioiodine Therapy in Patients with Metastatic Papillary, Follicular and Poorly Differentiated Thyroid Cancer. 88th Annual Meeting of the American Thyroid Association 29(S1), 2019. e-Pub 2019.
- Wirth LJ, Waguespack SG, Busaidy NL, Hu MI, Grubbs EG, Weitzman SP, Zafereo ME, Babiarz JE, Hao Y, Huang J, Kennedy GC, Walsh PS, Kloos RT. Genomic Landscape of FNAs positive for Medullary Thyroid Cancer (MTC) and Potential Impact on Systemic Therapy. 2019 ASCO Annual Meeting 37(15_suppl):6087-6087, 2019. e-Pub 2019.
- Thosani S, Best C, Lavis V, Habra M, Busaidy N, Varghese J, Hu M, Cabanillas M, Dadu R, Gagel R, Waguespack S, Weitzman SP, Jimenez C. Improving Documentation for Hypoglycemia Treatment in Hospitalized Patients at MD Anderson Cancer Center. The University of Texas MD Anderson Cancer Center Division of Internal Medicine Research Retreat, 2019.
- Waguespack S, Busaidy N, Hu M, Grubbs E, Weitzman SP, Wirth L, Zafereo M, Babiarz J, Hao Y, Huang J, Kennedy G, Walsh P, Kloos R. The Genomic Landscape of Preoperative FNAs Positive for the Afirma GSC Medullary Thyroid Cancer Classifier. The Endocrine Society 101st Annual Meeting 3(Supplement 1), 2019. e-Pub 2019.
- Kikani N, Chitrapu P, Weitzman SP. Addition of Everolimus to Lenvatinib Halts Tumor Progression in Differentiated Thyroid Cancer. 88th Annual Meeting of the American Thyroid Association 28(S1), 2018. e-Pub 2018.
- Kumar A, Weitzman SP. Was Atrial Fibrillation the Harbinger of a Thyrotroph Adenoma?. Endocrine Practice 24(4):181, 2018. e-Pub 2018.
- Cubb TD, Ibrahim EY, Sherman SI, Williams MD, Busaidy NL, Weitzman SP. From Thyroid Adenoma to Metastatic Carcinoma: Not All BRAF Mutations Are Created Equal. 87th Annual Meeting of the American Thyroid Association 27(S1):1-A-156, 2017. e-Pub 2017.
- Xu J, Murphy Jr WA, Milton DR, Rao SN, Jimenez J, Habra MA, Waguespack SG, Ying AK, Cabanillas ME, Cote GJ, Dadu R, Grubbs EG, Weitzman SP, Busaidy NL, Gagel RF, Sellin RV, Sherman SI, Hu MI. Medullary Thyroid Cancer with Bone Metastases and the Effect of Antiresorptive Agents on Skeletal Related Events: Experience at MD Anderson Cancer Center. The Endocrine Society 98th Annual Meeting 37(S1), 2016. e-Pub 2016.
- Weitzman SP, Cabanillas ME. Complete Biochemical and Structural Response in a Patient with Poorly Differentiated Thyroid Cancer on Cabozantinib. 15th International Thyroid Congress 25(S1):1-A-337, 2015. e-Pub 2015.
- Weitzman SP, Waguespack SG, Ying AK, Hu MI, Cabanillas ME. Pain May Represent Treatment Response to Targeted Therapy in Patients with Thyroid Cancer. 15th International Thyroid Congress 25(S1):P-1-A-337, 2015. e-Pub 2015.
- Cabanillas ME, Williams MD, Brandon GB, Weitzman SP, Burke L, Busaidy NL, Ying AK, William WN, Lu C, Lai S. Facilitating Anaplastic Thyroid Cancer Specialized Treatment (FAST): a Model for Increasing Enrollment to Anaplastic Thyroid Cancer (ATC) Clinical Trials. 15th International Thyroid Congress 25(S1):P-1-A-337, 2015. e-Pub 2015.
- Weitzman SP, Peicher KT, Dadu R, Hu MI, Jimenez C, Gardner C, Qayyum A, Hernandez M, Cabanillas ME. Salvage Therapy in Advanced Medullary Thyroid Cancer. University of Texas MD Anderson Cancer Center Division of Internal Medicine Research Retreat, 2015.
- Weitzman SP, Peicher KT, Dadu R, Hu MI, Jimenez C, Gardner C, Qayyum A, Hernandez M, Cabanillas ME. Salvage Therapy: When a Tyrosine Kinase Inhibitor Fails in Advanced Medullary Thyroid Cancer. The Endocrine Society 97th Annual Meeting 36(S1), 2015. e-Pub 2015.
- Gredysa B, Weitzman SP. The Unusual Outcome of an Usual Thyroid Nodule. 84th Annual Meeting of the American Thyroid Association 24(S1):P-1-A-123, 2014. e-Pub 2014.
- Maxwell C, Cella J, Weitzman SP, Yang J, Zhu J, Kapoor A. The Utility of Continued Ultrasound Surveillance of Thyroid Nodules. The Endocrine Society 95th Annual Meeting 34(S1), 2013. e-Pub 2013.
- Weitzman SP, Clarke G. Anaplastic Thyroid Cancer or Thyroiditis?. The Endocrine Society 95th Annual Meeting 34(S1), 2013. e-Pub 2013.
- Nunez CF, Weitzman SP. Fat in the Thyroid: a Rare Case of Thyroid Hürthle Cell Adenolipoma, 2013. e-Pub 2013.
- Balliu E, Shah N, Charitou MM, Weitzman SP. Zenker Diverticulum Presenting as a Thyroid Nodule: Two Case Reports, 2012. e-Pub 2012.
- Gupta A, Weitzman SP, Narula HS. Adrenal Adenoma and Coexistent Hemorrhagic Cyst Simulating an Adrenal Collision Tumor, 2009. e-Pub 2009.
- Carlson HE, Ginsburg KC, Weitzman SP. New Medications Which Interfere with the Absorption of Levothyroxine, 2008. e-Pub 2008.
- Carlson HE, Narula HS, Weitzman SP. Exogenous Thyrotoxicosis Due to a Compounding Pharmacy Error, 2008. e-Pub 2008.
Book Chapters
- Cabanillas ME, Weitzman SP, Dadu R, Gansler T, Zafereo M. Thyroid Cancer. In: The American Cancer Society's Oncology in Practice: Clinical Management. 1st. John Wiley & Sons, Inc, 519-531, 2018.
- Kwatampora LJ, Weitzman SP, Habra MA, Busaidy NL. Endocrine Malignancies. In: The MD Anderson Manual of Medical Oncology. 3rd. McGraw-Hill Medical, 903-932, 2016.
Patient Reviews
CV information above last modified September 08, 2026